🇬🇧 🇫🇷
S

Sangamo Therapeutics, Inc.

Biotechnology Research · United States · 500 employees

Biotechnology Research United States B2B Est. 1995
27 Decision makers
500 Employees
$35M Revenue
1995 Founded

Organizational Chart of Sangamo Therapeutics, Inc.

Roles identified within Sangamo Therapeutics, Inc.'s leadership team, from public professional data, updated 25 Oct 2026.

Department

Sangamo Therapeutics, Inc.'s Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People

Decision makers at Sangamo Therapeutics, Inc. by function

General management

Other functions

See all Sangamo Therapeutics, Inc. contacts on Zeliq

Decision makers at Sangamo Therapeutics, Inc.

27 identified 3 C-Level 5 VP 19 Directors
See them on Zeliq →

Funding and news at Sangamo Therapeutics, Inc.

Funding

Last round Other
Total funding $601M (11 rounds)
Series B $7M Jan 1998
Post-IPO Equity $74M Sep 2013
Post-IPO Equity $83M Jun 2017
Grant $11M Feb 2018
Post-IPO Equity $200M Apr 2018
Grant $8M Apr 2018
Post-IPO Equity $146M Apr 2019
Post-IPO Equity $24M Mar 2024
Post-IPO Equity $23M Jun 2025
Post-IPO Equity $25M Feb 2026
Post-IPO Debt N/A Jun 2026

Team Structure headcount by department

Research
51
Other
19
Operations
12
Project Management
10
General Management
9
Finance
8
Technical
8
Legal
6

How to prospect Sangamo Therapeutics, Inc.'s departments
Research

The company's largest department, with 51 people. Long cycles and rigorous methods: respect their pace and bring evidence, not hype.

Other

The company's second-largest department (19 people). Hard to read from the outside: use a first exchange to map who does what before pushing an offer.

Operations

A team of 12 people. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

Project Management

This department counts 10 people. Methodology debates are constant here: anchor your pitch in their existing framework rather than against it.

General Management

9 people work in this department. A good executive approach often starts lower in the organisation: build an internal champion before going top-down.

Finance

A team of 8 people. These decision makers arbitrate budgets: a well-quantified business case is your best door opener.

Try the Zeliq email finder demo →

FAQ Sangamo Therapeutics, Inc.

Who runs Sangamo Therapeutics, Inc.?

The highest-ranking leadership role identified at Sangamo Therapeutics, Inc. is “CEO”, based on public data updated 25 Oct 2026.

How many decision makers does Sangamo Therapeutics, Inc. have?

27 decision makers identified, including 3 at executive level.

How do I contact a decision maker at Sangamo Therapeutics, Inc.?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Companies similar to Sangamo Therapeutics, Inc.

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc. is a Biotechnology Research company, operating from United States. Established in 1995, it counts about 500 employees. Sangamo Therapeutics, Inc. belongs to the Professional Services sector, with a specific positioning on Biotechnology Research. Sangamo Therapeutics, Inc. sells primarily to other businesses (B2B) rather than to end consumers. Sangamo Therapeutics, Inc. has raised funding across 11 rounds totalling $601M. Its estimated yearly revenue stands at about $35M. The data below (industry, headcount, location and business signals) helps sales teams qualify Sangamo Therapeutics, Inc. and pinpoint the right decision makers from the first touchpoint.

Activity & Market

Sangamo Therapeutics, Inc. is positioned on the Biotechnology Research segment, within the Professional Services sector. As a B2B company, Sangamo Therapeutics, Inc. primarily serves business clients and professional organisations. The company is categorised as “Public company”.